Supreme Court Leaves Mifepristone Access Unchanged – For Now

A review of a certain medication's safety is underway. This process was started after some groups and officials made requests. The outcome of this review is not yet known. The agency in charge of this review is currently without a permanent leader, which may affect the timeline. Further information about this situation can be found through the KFF Women's Health Policy. Details about the review and its potential impact are limited, but it is known that the process adds uncertainty to the current situation. For more information, readers can consult the source directly.